Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Understanding the intricate relationship between payer control, channel distribution, and volume uptake can provide invaluable insights, not just within the diabetes and anti-obesity medicines (AOM) markets
A patient with a high BMI may meet more than one pathway (for example, BMI 38 with prior stroke meets Tier 1 by BMI alone and Tier 3 by stroke), and that overlap is fine
Particularly, the background anti-diabetic agents, lipid-lowering drugs, antiaggregants, and antihypertensives may affect cardiovascular events
If youre 2 to 5 lb above your target, the taper is fine
US$ 25.05
US$ 20.52
US$ 26.26
US$ 21.20
US$ 20.70
US$ 23.87
US$ 26.10
US$ 24.39
